Lin‐Yu Chen

Promoter hypermethylation of FBXO32, a novel TGF-β/SMAD4 target gene and tumor suppressor, is associated with poor prognosis in human ovarian cancer

Jian‐Liang Chou, Her‐Young Su, Lin‐Yu Chen et al. · Laboratory Investigation · 2010 · 114 citations · Full text

Medicine, Promoter Hypermethylation, Human Ovarian Cancer +9

Ascitic fluid shear stress in concert with hepatocyte growth factor drive stemness and chemoresistance of ovarian cancer cells via the c-Met-PI3K/Akt-miR-199a-3p signaling pathway

Ayon A. Hassan, Margarita Artemenko, Maggie K. S. Tang et al. · Cell Death and Disease · 2022 · 67 citations · Full text

Antioxidation and active constituents analysis of flower residue of Rosa damascena

Wenya Liu, Lin‐Yu Chen, Yingying Huang et al. · Chinese Herbal Medicines · 2020 · 46 citations · Full text

TET1 reprograms the epithelial ovarian cancer epigenome and reveals casein kinase 2α as a therapeutic target

Lin‐Yu Chen, Rui Huang, Michael WY Chan et al. · The Journal of Pathology · 2019 · 36 citations · Full text

GATA3 as a master regulator and therapeutic target in ovarian high‐grade serous carcinoma stem cells

H. Chen, Rui Huang, Phui‐Ly Liew et al. · International Journal of Cancer · 2018 · 34 citations · Full text